GENA ETTINGER: Open Payments
NPI 1578815304 · SOUTHLAKE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,869 in 36 payments from 8 companies in 2025. Trend: 2023 $27 · 2024 $1,624 · 2025 $6,869
Consulting: $3,645Food & beverage: $1,905Travel & lodging: $1,319
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 15 | $5,741 |
| ABBVIE INC. | 13 | $648 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $253 |
| Lilly USA, LLC | 2 | $83 |
| Mirum Pharmaceuticals, Inc. | 1 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Janssen Biotech, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $24 |
Products named: REZDIFFRA, SKYRIZI, XIFAXAN, OMVOH, RINVOQ, Livmarli, ENTYVIO, TREMFYA.
Industry payments across TX — which companies pay providers there.
